Инструмент | Доходность к погашению % | Объём | Цена % | Купонная доходность % | Срок погашения | Задолженность | Номинал | Мин. деноминация | Эмитент |
---|
Инструмент | Доходность к погашению % | Объём | Цена % | Купонная доходность % | Срок погашения | Задолженность | Номинал | Мин. деноминация | Эмитент |
---|---|---|---|---|---|---|---|---|---|
TKPH5010047Takeda Pharmaceutical Company Limited 3.175% 09-JUL-2050 D | 6,98% | 400 K | 65,09% | 3,18% | 2050-07-09 | 2 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
TKPH5010048Takeda Pharmaceutical Company Limited 3.375% 09-JUL-2060 D | 6,94% | 2 M | 63,46% | 3,38% | 2060-07-09 | 1 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
TKPH5010046Takeda Pharmaceutical Company Limited 3.025% 09-JUL-2040 D | 6,51% | 400 K | 73,08% | 3,03% | 2040-07-09 | 1,5 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
TTKPH4369980Baxalta Incorporated 5.25% 23-JUN-2045 D | 6,05% | 55 K | 92,70% | 5,25% | 2045-06-23 | 500,41 M USD | 1 000,00 USD | 2 000,00 USD | Baxalta, Inc. |
TKPH5841810Takeda Pharmaceutical Company Limited 5.8% 05-JUL-2064 D | 6,04% | 1 M | 97,16% | 5,80% | 2064-07-05 | 500 M USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
TKPH5841809Takeda Pharmaceutical Company Limited 5.65% 05-JUL-2054 D | 5,97% | 690 K | 96,53% | 5,65% | 2054-07-05 | 600 M USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
TKPH5841808Takeda Pharmaceutical Company Limited 5.65% 05-JUL-2044 D | 5,81% | 2,68 M | 98,50% | 5,65% | 2044-07-05 | 800 M USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
TKPH5010045Takeda Pharmaceutical Company Limited 2.05% 31-MAR-2030 D | 5,50% | 300 K | 85,91% | 2,05% | 2030-03-31 | 2,5 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
TKPH5841807Takeda Pharmaceutical Company Limited 5.3% 05-JUL-2034 D | 5,49% | 1,03 M | 98,79% | 5,30% | 2034-07-05 | 1,1 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
UUS82481LAD1SHIRE ACQUIST.I.IE 16/26 D | 4,98% | 0 | 97,17% | 3,20% | 2026-09-23 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Shire Acquisitions Investments Ireland DAC |
TKPH4770188Takeda Pharmaceutical Company Limited 5.0% 26-NOV-2028 D | 4,96% | 328 K | 100,14% | 5,00% | 2028-11-26 | 1,73 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
TTKPH4370840Baxalta Incorporated 4.0% 23-JUN-2025 D | 4,95% | 3 K | 99,55% | 4,00% | 2025-06-23 | 800,17 M USD | 1 000,00 USD | 2 000,00 USD | Baxalta, Inc. |
TKDBTAKEDA PHARMA. 20/40 D | 4,30% | 0 | 78,58% | 2,00% | 2040-07-09 | 1 B EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
XS219734964TAKEDA PHARMA. 20/32 D | 3,50% | 0 | 87,32% | 1,38% | 2032-07-09 | 1 B EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
XS184344939TAKEDA PHARMA.18/30 REGS D | 3,20% | 0 | 98,99% | 3,00% | 2030-11-21 | 1,5 B EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
XS219734859TAKEDA PHARMA. 20/29 D | 3,11% | 0 | 91,63% | 1,00% | 2029-07-09 | 850 M EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
XS219734832TAKEDA PHARMA. 20/27 D | 2,88% | 0 | 95,00% | 0,75% | 2027-07-09 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
XS184344912TAKEDA PHARMA. 18/26 REGS D | 2,75% | 0 | 99,10% | 2,25% | 2026-11-21 | 1,5 B EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
TKPH4770186Takeda Pharmaceutical Company Limited 5.0% 26-NOV-2028 D | 2,71% | 0 | 116,57% | 5,00% | 2028-11-26 | 22,68 M USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |
SSHPG4260178Baxalta Incorporated 4.0% 23-JUN-2025 D | — | — | — | 4,00% | 2025-06-23 | 303 K USD | 1 000,00 USD | 2 000,00 USD | Baxalta, Inc. |
TKPH4770187Takeda Pharmaceutical Company Limited 5.0% 26-NOV-2028 D | — | — | — | 5,00% | 2028-11-26 | 22,68 M USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |